The Foundation of the National Lipid Association (FNLA) supports patient and clinician educational, research, and community outreach activities that enhance and support the initiatives of the NLA in its efforts to reduce cardiovascular events and deaths related to abnormalities of cholesterol metabolism.

Article By:

FOUNDATION OF NLA ANNUAL REPORT
0
No votes yet

Pamela Morris, MD, is currently an associate professor at the Medical University of South Carolina where she serves as director of the Seinsheimer Cardiovascular Health Program and co- director of Women’s Heart Care. She is also the chair of the American College of Cardiology’s Prevention of Cardiovascular Disease Leadership Council and Section.

Article By:

PAMELA B. MORRIS, MD, FACC, FACP, FACPM, FAHA, FNLA
Director, Preventive Cardiology
Co-Director, Women’s Heart Care
Medical University of South Carolina
Charleston, SC

Diplomate, American Board of Clinical Lipidology

0
No votes yet

“What a day that was” – David Byrne, Talking Heads, Stop Making Sense

Article By:

HAROLD E. BAYS, MD, FTOS, FACC, FACE, FNLA
President, Southeast Lipid Association
Secretary, National Lipid Association
Medical Director/President
Louisville Metabolic and Atherosclerosis Research Center
Louisville, KY

Diplomate, American Board of Clinical Lipidology

0
No votes yet

Case:

Article By:

PAVANI KOLAKALAPUDI, MD
Division of Cardiovascular Medicine
University of South Alabama
Mobile, AL

 

BASSAM OMAR, MD, PhD, FACC, FAHA
Division of Cardiovascular Medicine
University of South Alabama
Mobile, AL

Diplomate, American Board of Clinical Lipidology

0
No votes yet

When treating our lipid patients it is important to always consider unusual causes of dyslipidemia in our differential diagnosis.

Article By:

DEBRA A. FRIEDRICH, DNP, FNP-BC, BC-ADM, FAANP, FNLA
Assistant Professor
DNP Post-Master’s Director
University of South Florida, College of Nursing
Bradenton, FL

Diplomate, American Board of Clinical Lipidology

0
No votes yet

This is the case of a 68-year-old white female who was being seen in her home in August 2014 as part of a health evaluation for her insurance company. She had a history of hyperlipidemia, hypertension, and diabetes mellitus. She had been placed on atorvastatin five years prior to this visit and developed significant myalgia with an elevation in her creatine phosphokinase (CPK) level to 250 mg/dL per patient.

Article By:

RALPH VICARI, MD, FACC, FNLA
Vice President, Foundation of the National Lipid Association
Founder, MIMA Century Research
Associate Professor of Cardiovascular Medicine
Department of Medical Education
University of Central Florida College of Medicine
Melbourne, FL

Diplomate, American Board of Clinical Lipidology

MAYA N. ROA-SEGURA, PharmD, BCPS
Clinical Pharmacy Specialist
Primary and Interim Care
Veterans Health Administration
Orlando VA Medical Center, Outpatient Clinic
Viera, FL

0
No votes yet

Sitosterolemia is a rare, autosomal, recessively inherited sterol storage disease caused by homozygous or compound heterozygous gene mutations of adenosine triphosphate-binding cassette (ABC) genes G5 or G8, in which markedly increased tissue and plasma plant sterol concentrations. The condition can lead to premature atherosclerosis and has also been described as phytosterolemia and Beta-Sitosterolemia.1-4

Article By:

CASEY ELKINS, DNP, NP-C
Assistant Professor
University of South Alabama, College of Nursing
Mobile, AL
Director/Founder
The Lipid Center at Cooper Family Medical Center
Pascagoula, MS

Diplomate, Accreditation Council of Clinical Lipidology

0
No votes yet

An exciting new approach to treating obesity and insulin resistance involves significant carbohydrate restriction with the goal of achieving a ketogenic state that results in weight loss and improved insulin sensitivity. Many lipidologists, however, have seen frequent cases of worsening lipid and lipoprotein parameters with such carbohydrate-restricted diets.

Article By:

GREGORY S. POKRYWKA, MD, FACP, NCMP, FNLA
Director, Baltimore Lipid Center
Assistant Professor, Johns Hopkins University School of Medicine
Baltimore, MD

Diplomate, American Board of Clinical Lipidology

0
No votes yet

Introduction

Article By:

DEBORAH S. CROY, DNP, ANP-BC, AGPCNP-BC, AACC
Treasurer, Southeast Lipid Association
Adult Nurse Practitioner
Bland County Medical Clinic
Bastian, VA

Diplomate, Accreditation Council of Clinical Lipidology

DAVE L. DIXON, PharmD, AACC, CDE, BCPS-AQ Cardiology, FNLA
Assistant Professor and Vice-Chair of Clinical Services
Department of Pharmacotherapy & Outcomes Science
Virginia Commonwealth University School of Pharmacy
Richmond, VA

Diplomate, Accreditation Council of Clinical Lipidology

LINDSEY KENNEDY, RN, BSN
Family Nurse Practitioner Student
University of Virginia
Charlottesville, VA
Registered Nurse
Bland County Medical Clinic
Bastian, VA

0
No votes yet

This edition of the LipidSpin is an outstanding representation of how there is never a dull moment in the world of clinical lipidology. This SELA edition of LipidSpin has many outstanding lessons and insights nested within the various articles. As I read through this edition, two things stand out to me as highly noteworthy: collaboration and quality.

Article By:

JOSEPH J. SASEEN, PharmD, BCPS, BCACP, FNLA
Professor, Clinical Pharmacy and Family Medicine
University of Colorado Denver
Anschutz Medical Campus
Aurora, CO

Diplomate, American Board of Clinical Lipidology

0
No votes yet